Gabarol CR 330 Cr Tablet

About Gabarol CR 330 Cr Tablet

Gabarol CR 330 is a controlled-release tablet made by Advanced Chemical Industries PLC that contains 330 mg of pregabalin. It is an add-on anti-epileptic medicine, and a doctor decides how it is taken and for how long.

There are 105 brands of Pregabalin listed in Bangladesh. The lowest listed price is GAPA-P 150 mg Capsule at ৳ 1 per unit.

What is Gabarol CR 330 Cr Tablet?

Gabarol CR 330 is a controlled-release tablet containing 330 mg of pregabalin, supplied by Advanced Chemical Industries PLC. Pregabalin belongs to a group of medicines used as add-on (adjunct) treatment for epilepsy. It is also used in certain nerve pain conditions and in fibromyalgia. The tablet is designed to release the medicine gradually, so it is usually taken as directed by the doctor. Only a doctor can decide whether it suits a particular person, what amount to take and how long treatment should continue. Ask the doctor or pharmacist about anything that is unclear before starting.

Uses of Gabarol CR 330

Gabarol CR 330 is used as an add-on treatment for partial-onset seizures, meaning it is taken alongside other epilepsy medicines rather than alone. Pregabalin is also used for some types of nerve pain, such as nerve pain from diabetes or after shingles, for fibromyalgia, and for nerve pain linked to spinal cord injury. Whether it is suitable for a particular person is a decision for the doctor, who will consider the condition and the person's overall health.

How to use Gabarol CR 330

Gabarol CR 330 is a controlled-release tablet, so it is meant to be swallowed whole rather than crushed or chewed. The doctor decides the amount, how often it is taken and how long the course lasts. Do not change the amount or stop suddenly on your own, because the doctor plans these steps. If a dose is missed or you are unsure how to take it, ask the doctor or pharmacist for advice. Keep the tablet in a cool, dry place, away from light and moisture, and out of reach of children.

Side effects of Gabarol CR 330

Common side effects reported with pregabalin include dizziness, drowsiness, dry mouth, swelling, blurred vision, weight gain and difficulty concentrating. In children treated for partial-onset seizures, increased weight and increased appetite are common. Some people may develop serious reactions such as swelling of the throat, head or neck, or allergic reactions like hives, breathing difficulty and wheezing; these need urgent medical attention. Pregabalin can also increase the risk of suicidal thoughts or behaviour. Tell the doctor about any side effect, and seek help quickly if symptoms are severe.

Safety and precautions

Pregabalin has not been adequately studied in pregnant women, so pregnant women should be told about the possible risk to the fetus. Small amounts pass into breast milk, and breastfeeding is not recommended during treatment because of a potential risk of tumour formation. Pregabalin can cause breathing depression when taken with other medicines that depress the central nervous system, or in people with existing breathing problems. It can also raise the risk of suicidal thoughts or behaviour. Tell the doctor about pregnancy, breastfeeding, breathing problems, allergies or other medicines before starting, and ask the doctor first if any of these apply.

Frequently asked questions

How should Gabarol CR 330 be taken?

It is a controlled-release tablet, so it is usually swallowed whole, not crushed or chewed. The doctor decides the amount, how often it is taken and how long the course lasts. Do not change or stop it on your own; ask the doctor or pharmacist if anything is unclear.

What is Gabarol CR 330 used for and what kind of medicine is it?

It contains pregabalin, an add-on anti-epileptic medicine used alongside other medicines for partial-onset seizures. Pregabalin is also used for some nerve pain conditions, fibromyalgia and nerve pain after spinal cord injury. The doctor decides whether it is suitable for a person.

Is Gabarol CR 330 safe in pregnancy or breastfeeding?

Pregabalin has not been adequately studied in pregnant women, so the possible risk to the fetus should be discussed with the doctor. Small amounts pass into breast milk, and breastfeeding is not recommended during treatment. Tell the doctor if you are pregnant, planning pregnancy or breastfeeding.

What should I tell the doctor before starting Gabarol CR 330?

Tell the doctor about pregnancy or breastfeeding, breathing problems, allergies to pregabalin or any tablet ingredient, and all other medicines you take, including those that cause drowsiness. Pregabalin can raise the risk of suicidal thoughts, so mention any such history. The doctor will decide whether it is suitable.

Indications

Pregabalin is indicated for:
  • Neuropathic pain associated with diabetic peripheral neuropathy (DPN)
  • Postherpetic neuralgia (PHN)
  • Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older
  • Fibromyalgia
  • Neuropathic pain associated with spinal cord injury
  • ... Read more
Pregabalin is indicated for:
  • Neuropathic pain associated with diabetic peripheral neuropathy (DPN)
  • Postherpetic neuralgia (PHN)
  • Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older
  • Fibromyalgia
  • Neuropathic pain associated with spinal cord injury
Pregabalin CR tablet is indicated for:
  • Neuropathic pain associated with diabetic peripheral neuropathy (DPN)
  • Postherpetic neuralgia (PHN)

Pharmacology

Pregabalin is a structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA). It does not bind directly to GABAA, GABAB or benzodiazepine receptors. Pregabalin binds with high affinity to the alpha2-delta site (an auxiliary subunit of voltage-gated calcium channels) in central nervous system tissues. Although the mechanism of action of Pregabalin has not been fully elucidated, results in animal studies suggest that binding to the alpha2-delta subunit may be involved in Pregabalin's anti-nociceptive and antiseizure effects.

Dosage & Administration

Neuropathic pain associated with diabetic peripheral neuropathy in adults (DPN): The maximum recommended dose of Pregabalin is 100 mg three times a day (300 mg/day) in patients with creatinine clearance of at least 60 ml/min. Dosing should begin at 50 mg three times a day (150 mg/day). The dose may be increased to 300 mg/day within 1 week based on efficacy and tolerability. Begin dosing of Pregabalin CR capsule at 165 mg once daily and increase to 330 mg once daily within 1 week based on individual patient response and tolerability. The maximum recommended dose of Pregabalin CR capsule is 330 mg once daily.

Postherpetic neuralgia in adults (PHN): The recommended dose of Pregabalin is 75 to 150 mg two times a day or 50 to 100 mg three times a day (150 to 300 mg/day) in patients with creatinine clearance of at least 60 ml/min. Dosing should begin at 75 mg two times a day or 50 mg three times a day (150 mg/day). The dose may be increased to 300 mg/day within 1 week based on efficacy and tolerability. Patients who do not experience sufficient pain relief following 2 to 4 weeks of treatment with 300 mg/day and who are able to tolerate Pregabalin, may be treated with up to 300 mg two times a day or 200 mg three times a day (600 mg/day).

Begin dosing of Pregabalin CR capsule at 165 mg once daily and increase to 330 mg once daily within 1 week based on individual patient response and tolerability. Patients who do not experience sufficient pain relief following 2 to 4 weeks of treatment with 330 mg once daily and who are able to tolerate Pregabalin CR capsule, may be treated with up to 660 mg once daily. In view of the dose-dependent adverse reactions and the higher rate of treatment discontinuation due to adverse reactions, dosing above 330 mg/day should be reserved only for those patients who have on-going pain and are tolerating 330 mg daily. The maximum recommended dose of Pregabalin CR capsule is 660 mg once daily.

Management of fibromyalgia in adults: The recommended dose of Pregabalin is 300 to 450 mg/day. Dosing should begin at 75 mg two times a day (150 mg/day). The dose may be increased to 150 mg two times a day (300 mg/day) within 1 week based on efficacy and tolerability. Patients who do not experience sufficient benefit with 300 mg/day may be further increased to 225 mg two times a day (450 mg/day).

Neuropathic pain associated with spinal cord injury in adults: The recommended dose range of Pregabalin is 150 to 600 mg/day. The recommended starting dose is 75 mg two times a day (150 mg/day). The dose may be increased to 150 mg two times a day (300 mg/day) within 1 week based on efficacy and tolerability. Patients who do not experience sufficient pain relief after 2 to 3 weeks of treatment with 150 mg two times a day and who tolerate Pregabalin may be treated with up to 300 mg two times a day.

Conversion from Pregabalin capsules to Pregabalin CR capsule tablet: When switching from Pregabalin capsules to Pregabalin CR capsule tablet on the day of the switch, instruct patients to take their morning dose of Pregabalin capsule as prescribed and initiate Pregabalin CR capsule therapy after an evening meal.

Pregabalin tablet total daily dose (dosed 2 or 3 times daily): Pregabalin CR capsule capsule dose (dosed once a day)
  • 75 mg/daily: 82.5 mg/day
  • 150 mg/daily: 165 mg/day
  • 225 mg/daily: 247.5 mg/day
  • 300 mg/daily: 330 mg/day
  • 450 mg/daily: 495 mg/day
  • 600 mg/daily: 660 mg/day

Interaction

Pregabalin is unlikely to be involved in significant pharmacokinetic drug interactions.

Contraindications

Pregabalin is contraindicated in patients with known hypersensitivity to Pregabalin or any of its components.

Side Effects

Most common side effects in adults are dizziness, somnolence, dry mouth, edema, blurred vision, weight gain and thinking abnormal (primarily difficulty with concentration/attention). Most common side effects in pediatric patients for the treatment of partial onset seizures are increased weight and increased appetite.

Pregnancy & Lactation

There are no adequate and well-controlled studies with pregabalin in pregnant women. Pregnant women should be advised of the potential risk to a fetus. Small amounts of pregabalin have been detected in the milk of lactating women. Because of the potential risk of tumorigenicity, breastfeeding is not recommended during treatment with pregabalin.

Precautions & Warnings

Angioedema (e.g., swelling of the throat, head and neck) can occur and may be associated with life threatening respiratory compromise requiring emergency treatment. Pregabalin should be discontinued immediately in these cases. Pregabalin should also be discontinued immediately if hypersensitivity reactions (e.g., hives, dyspnea and wheezing) occur. Antiepileptic drugs, including pregabalin, increase the risk of suicidal thoughts or behavior. Respiratory depression may occur with pregabalin when used with concomitant CNS depressants or in the setting of underlying respiratory impairment. Patients need to be monitored and dosage adjusted as appropriate. Pregabalin may cause dizziness and somnolence and impair patients ability to drive or operate machinery. Increased seizure frequency or other adverse reactions may occur if pregabalin is rapidly discontinued. Pregabalin should be withdrawn gradually over a minimum of 1 week. Pregabalin may cause peripheral edema. Caution should be exercised when coadministering pregabalin and thiazolidinedione antidiabetic agents.

Overdose Effects

In case of overdose with pregabalin, sign and symptoms are reduced consciousness, depression/anxiety, confusional state, agitation and restlessness. Seizures and heart block have also been reported. There is no specific antidote. If indicated, elimination of unabsorbed drug may be attempted by emesis or gastric lavage; usual precautions should be observed to maintain the airway. General supportive care of the patient is indicated including monitoring of vital signs and observation of the clinical status of the patient.

Storage Conditions

Keep in a cool & dry place (below 30°C), protected from light & moisture. Keep out of the reach of children.

Alternative brands of Pregabalin

Other brands with the same generic name, cheapest first.

Asibalin Capsule

25 mg

Pregabalin

Asiatic Laboratories Ltd.

৳ 7.84 ৳ 8.00 2% off per unit

Gabarol Capsule

25 mg

Pregabalin

Advanced Chemical Industries PLC

৳ 10.78 ৳ 11.00 2% off per unit

Algaba Capsule

50 mg

Pregabalin

Al-Madina Pharmaceuticals Ltd.

৳ 11.76 ৳ 12.00 2% off per unit

Asibalin Capsule

50 mg

Pregabalin

Asiatic Laboratories Ltd.

৳ 11.76 ৳ 12.00 2% off per unit

Broklin Capsule

50 mg

Pregabalin

One Pharma Ltd.

৳ 12.74 ৳ 13.00 2% off per unit

Neugalin Capsule

50 mg

Pregabalin

The ACME Laboratories Ltd.

৳ 14.31 ৳ 14.6 2% off per unit

See all 105 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.